National Vision Holdings, Inc.

EYE ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $1.99B $7.00B $5.70B $4.54B $3.76B $2.91B $2.32B $1.73B
Products $6.20B $5.10B $4.12B $3.45B $2.68B $2.15B $1.62B
Services $800.0M $600.0M $420.2M $310.4M $225.6M $165.2M $110.5M
Cost of Revenue $713.6M
Gross Profit $1.02B
Gross Margin 58.8%
Operating Expenses
Research & Development
SG&A Expense $1.02B $938.5M $904.8M $832.6M $725.0M $744.5M $687.5M
Operating Income $58.8M $-10.4M $24.5M $52.8M $87.0M $73.6M $42.4M
Operating Margin 3.0% -0.1% 0.4% 1.2% 2.3% 3.2% 2.4%
Interest Expense $25.6M $48.3M $33.3M $37.3M
Pretax Income $41.7M $-25.7M $9.6M $52.3M $38.7M $30.5M $4.9M
Income Tax Expense $12.1M $1.5M $6.0M $15.5M $2.4M $-2.3M $-18.8M
Net Income $29.6M $-28.5M $-65.9M $42.1M $36.3M $32.8M $23.7M
Net Margin 1.5% -0.4% -1.2% 0.9% 1.0% 1.4% 1.4%
EPS (Basic) $0.37 $-0.36 $-0.84 $0.53 $0.45 $0.42 $0.31
EPS (Diluted) $0.37 $-0.36 $-0.84 $0.52 $0.44 $0.40 $0.30
Shares Outstanding (Basic) 79.1M 78.6M 78.3M 79.8M 80.6M 80.2M 78.6M 75.9M
Shares Outstanding (Diluted) 80.6M 78.6M 78.6M 80.3M 82.8M 80.2M 81.7M 79.0M
Dividends Per Share
← Newer Page 1 of 3 Older →